Concepedia

LBA48 DUBLIN-3 (BPI-2358-103): A global phase (Ph) III trial with the plinabulin/docetaxel (Plin/Doc) combination vs. Doc in 2nd/3rd Line NSCLC patients (pts) with EGFR-wild type (wt) progressing on a prior platinum-based regimen

Baohui Han, Y-K. Shi, Trevor Feinstein, Dagan Feng, D. Mitchell, Yvette Lelorier, Lili Du, Lu Huang, Ramon Mohanlal, Yongkun Sun

Annals of Oncology · 2021 · 11 citations · 0 references

DOIFull text

Open access

Concepts